Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.12 HKD
−745.17 M HKD
0.00 HKD
516.52 M
About GENOR BIOPHARMA HLDGS LTD
Sector
Industry
CEO
Feng Guo
Website
Headquarters
Shanghai
Founded
2007
FIGI
BBG00XC7TCX4
Genor Biopharma Holdings Ltd. engages in the development and commercialization of oncology and autoimmune drugs. The company was found on April 10, 2007 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6998 is 1.70 HKD — it has increased by 2.41% in the past 24 hours. Watch GENOR BIOPHARMA HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GENOR BIOPHARMA HLDGS LTD stocks are traded under the ticker 6998.
6998 stock has risen by 2.41% compared to the previous week, the month change is a 21.43% rise, over the last year GENOR BIOPHARMA HLDGS LTD has showed a 44.07% increase.
6998 reached its all-time high on Oct 7, 2020 with the price of 32.20 HKD, and its all-time low was 0.85 HKD and was reached on Feb 1, 2024. View more price dynamics on 6998 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6998 stock is 4.22% volatile and has beta coefficient of 0.35. Track GENOR BIOPHARMA HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is GENOR BIOPHARMA HLDGS LTD there?
Today GENOR BIOPHARMA HLDGS LTD has the market capitalization of 857.42 M, it has decreased by −5.68% over the last week.
Yes, you can track GENOR BIOPHARMA HLDGS LTD financials in yearly and quarterly reports right on TradingView.
GENOR BIOPHARMA HLDGS LTD is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
6998 net income for the last half-year is −136.21 M HKD, while the previous report showed −431.93 M HKD of net income which accounts for 68.47% change. Track more GENOR BIOPHARMA HLDGS LTD financial stats to get the full picture.
No, 6998 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 28, 2024, the company has 104.00 employees. See our rating of the largest employees — is GENOR BIOPHARMA HLDGS LTD on this list?
Like other stocks, 6998 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOR BIOPHARMA HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOR BIOPHARMA HLDGS LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOR BIOPHARMA HLDGS LTD stock shows the neutral signal. See more of GENOR BIOPHARMA HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.